Efficacy Of Royal Philips Electronics N.V.' Stellarex .035" Low-Dose Drug-Coated Balloon Demonstrated In Clinical Trial At Two Years Post author:Sam Post published:September 14, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Gelesis Secures $30 Million to Support Potential Approval of Weight Loss Drug February 28, 2018 CARsgen Therapeutics Joins The Alliance For Regenerative Medicine June 29, 2017 IsoRay Announces Appointment Of As Controller, Principal Accounting And Financial Officer July 6, 2017
IsoRay Announces Appointment Of As Controller, Principal Accounting And Financial Officer July 6, 2017